Global /South Korea /Healthcare /Drug Manufacturers - Specialty & Generic /004720

PharmGen Science, Inc.

004720

• KRX: 004720 • Delayed

4,195KRW 0.5%

2.74 USD

As of 6 June 2026, PharmGen Science, Inc. has a market cap of $59.68M USD, ranking #29287 globally and #1598 in South Korea. It ranks #2654 in the Healthcare sector, and #148 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

29287

Country Rank

1598

Sector Rank

2654

Industry Rank

148

Key Stats

Market Cap

$59.68MUSD

91.49B KRW

Enterprise Value

$63.17MUSD

96.83B KRW

Revenue (TTM)

$111.99MUSD

171.66B KRW

EBITDA (TTM)

$9.32MUSD

14.29B KRW

Net Income (TTM)

$76.82KUSD

117.75M KRW

EBITDA Margin

8.3%

Profit Margin

0.1%

PE Ratio

776.9

PS Ratio

0.5

PB Ratio

0.4

EV/EBITDA

14.0

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

226

Founded

1957

Website

wooridulpharm.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.5%	9%	9.4%	-1.9%	0.5%	0.5%	2.1%	-35%	-66%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	004720 (주)팜젠사이언스 ISIN: KR7004720009 Shares Out.: Shares Outstanding: 22.612M¹ Shares Float: 17.101M² TV: TradingView: KRX: 004720 SA: Stock Analysis: KRX: 004720 YF: Yahoo Finance: 004720.KS GF: Google Finance: KRX: 004720 BA: Barron's: 004720 MS: Morningstar: XKRX: 004720	4,195 KRW	TV: TradingView: KRX: 004720 SA: Stock Analysis: KRX: 004720 YF: Yahoo Finance: 004720.KS GF: Google Finance: KRX: 004720 BA: Barron's: 004720 MS: Morningstar: XKRX: 004720

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About PharmGen Science, Inc.

PharmGen Science, Inc. engages in the research and development, production, and sale of pharmaceutical products in South Korea. It provides prescription drugs, OTC drugs, diagnostic test kits, health and general foods, and cosmetics, as well as shampoo, conditioner, and hair oil products under the neomcell brand name. The company was formerly known as Wooridul Pharmaceutical Limited and changed its name to PharmGen Science, Inc. PharmGen Science, Inc. was founded in 1957 and is headquartered in Hwaseong-si, South Korea.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Myung In Pharmaceutical LTD. KRX: 317450	$539.11M 826.36B KRW 803%	8.4	South Korea
FutureChem Co.,Ltd KRX: 220100	$278.08M 426.25B KRW 366%	-	South Korea
KOLMAR BNH Co.,Ltd. KRX: 200130	$218.56M 335.01B KRW 266%	-	South Korea
Kwang Dong Pharmaceutical Co., Ltd. KRX: 009290	$203.29M 311.61B KRW 241%	16.3	South Korea
NOVAREX Co.,Ltd. KRX: 194700	$167.22M 256.31B KRW 180%	7.4	South Korea
Kyung Dong Pharmaceutical Co., Ltd. KRX: 011040	$98.78M 151.41B KRW 66%	17.8	South Korea

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.66B 108.92B ILS 63K%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 49K%	-	United States
Zhejiang NHU Company Ltd. SHE: 002001	$15.86B 107.34B CNY 26K%	16.0	China
Cipla Ltd. NSE: CIPLA	$11.12B 1.06T INR 19K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.0B 1.05T INR 18K%	22.7	India
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.1B 61.6B CNY 15K%	80.6	China

chevron_leftBack